STAT3 Regulation By S-Nitrosylation: Implication In Cancer - PubMed (original) (raw)
STAT3 Regulation By S-Nitrosylation: Implication In Cancer
Inderjit Singh et al. Redox Biol. 2015 Aug.
Free article
Abstract
In this study, we assessed S-nitrosylation-based regulation of Janus-activated kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway. Our studies show that STAT3 in stimulated microglia underwent two distinct redox-dependent modifications, S-nitrosylation and S-glutathionylation. STAT3 S-nitrosylation was associated with inducible nitric oxide synthase (iNOS)-produced nitric oxide (NO) and S-nitrosoglutathione (GSNO), whereas S-glutathionylation of STAT3 was associated with cellular oxidative stress. NO produced by iNOS or treatment of microglia with exogenous GSNO inhibited STAT3 activation via inhibiting STAT3 phosphorylation (Tyr705). Consequently, the interleukin-6 (IL-6)-induced microglial proliferation and associated gene expressions were also reduced. In cell-free kinase assay using purified JAK2 and STAT3, STAT3 phosphorylation was inhibited by its selective preincubation with GSNO, but not by preincubation of JAK2 with GSNO, indicating that GSNO-mediated mechanisms inhibit STAT3 phosphorylation through S-nitrosylation of STAT3 rather than JAK2. In this study, we identified that Cys259 was the target Cys residue of GSNO-mediated S-nitrosylation of STAT3. The replacement of Cys259 residue with Ala abolished the inhibitory role of GSNO in IL-6-induced STAT3 phosphorylation and transactivation, suggesting the role of Cys259S-nitrosylation in STAT3phosphorylation. Since STAT3 activation is involved in tumor progression and metastasis, we investigated the effect of GSNO in cell culture and mouse xenograft model of head and neck squamous cell carcinoma (HNSCC). GSNO treatment of HNSCCN cell lines reversibly decreases the activation (phosphorylation) of STAT3 in a concentration dependent manner. The reduced STAT3/NF-kB activity by GSNO correlated with decreased cell proliferation and increased apoptosis of HNSCC cells. In HNSCC mouse xenograft model, the tumor growth was reduced by systemic treatment with GSNO and was further reduced when the treatment combined with radiation and cisplatin. Accordingly, GSNO treatment also resulted in decreased levels of pSTAT3 and tumor growth regulators (ie. cyclin D2, VEGF and Bcl-2) in tumor tissue. In summary, these findings have implications for the development of new therapeutics targeting of STAT3 for treating diseases associated with inflammatory/immune responses and abnormal cell proliferation, including cancer.
Copyright © 2015. Published by Elsevier B.V.
Similar articles
- STAT3 regulation by S-nitrosylation: implication for inflammatory disease.
Kim J, Won JS, Singh AK, Sharma AK, Singh I. Kim J, et al. Antioxid Redox Signal. 2014 Jun 1;20(16):2514-27. doi: 10.1089/ars.2013.5223. Epub 2014 Feb 14. Antioxid Redox Signal. 2014. PMID: 24063605 Free PMC article. - S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
Kaliyaperumal K, Sharma AK, McDonald DG, Dhindsa JS, Yount C, Singh AK, Won JS, Singh I. Kaliyaperumal K, et al. Redox Biol. 2015 Dec;6:41-50. doi: 10.1016/j.redox.2015.07.001. Epub 2015 Jul 2. Redox Biol. 2015. PMID: 26177470 Free PMC article. - The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells.
Yang X, He G, Hao Y, Chen C, Li M, Wang Y, Zhang G, Yu Z. Yang X, et al. J Neuroinflammation. 2010 Sep 9;7:54. doi: 10.1186/1742-2094-7-54. J Neuroinflammation. 2010. PMID: 20828402 Free PMC article. - The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications.
Chiueh CC, Rauhala P. Chiueh CC, et al. Free Radic Res. 1999 Dec;31(6):641-50. doi: 10.1080/10715769900301211. Free Radic Res. 1999. PMID: 10630687 Review. - Glutathione in Protein Redox Modulation through S-Glutathionylation and S-Nitrosylation.
Kalinina E, Novichkova M. Kalinina E, et al. Molecules. 2021 Jan 15;26(2):435. doi: 10.3390/molecules26020435. Molecules. 2021. PMID: 33467703 Free PMC article. Review.
Cited by
- Pillars and Gaps of S-Nitrosylation-Dependent Epigenetic Regulation in Physiology and Cancer.
Salvatori L, Spallotta F, Gaetano C, Illi B. Salvatori L, et al. Life (Basel). 2021 Dec 17;11(12):1424. doi: 10.3390/life11121424. Life (Basel). 2021. PMID: 34947954 Free PMC article. Review. - S-nitrosylation of the Peroxiredoxin-2 promotes S-nitrosoglutathione-mediated lung cancer cells apoptosis via AMPK-SIRT1 pathway.
Zhang Y, Sun C, Xiao G, Shan H, Tang L, Yi Y, Yu W, Gu Y. Zhang Y, et al. Cell Death Dis. 2019 Apr 15;10(5):329. doi: 10.1038/s41419-019-1561-x. Cell Death Dis. 2019. PMID: 30988280 Free PMC article. - S-Nitroso-L-Cysteine Ameliorated Pulmonary Hypertension in the MCT-Induced Rats through Anti-ROS and Anti-Inflammatory Pathways.
Wang M, Luo P, Shi W, Guo J, Huo S, Yan D, Peng L, Zhang C, Lv J, Lin L, Li S. Wang M, et al. Oxid Med Cell Longev. 2021 Jan 28;2021:6621232. doi: 10.1155/2021/6621232. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33574976 Free PMC article. Retracted. - Extensive protein S-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis.
Tan C, Li Y, Huang X, Wei M, Huang Y, Tang Z, Huang H, Zhou W, Wang Y, Hu J. Tan C, et al. Cell Death Dis. 2019 Dec 4;10(12):914. doi: 10.1038/s41419-019-2144-6. Cell Death Dis. 2019. PMID: 31801946 Free PMC article. - S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
Saxena N, Won J, Choi S, Singh AK, Singh I. Saxena N, et al. Free Radic Biol Med. 2018 Jun;121:57-68. doi: 10.1016/j.freeradbiomed.2018.04.558. Epub 2018 Apr 22. Free Radic Biol Med. 2018. PMID: 29694854 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous